Alector, Inc.
ALECHealthcare|Biotechnology|US
$2.29
+0.20 (+9.57%)
Tangible Book / Share
$1.05
Graham Number
$2.96
Cash / Share
$1.25
About
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Stock Price
+76.2%(1Y)
1M
+13.4%
3M
+28.7%
6M
+9.0%
YTD
+46.8%
1Y
+74.8%
3Y
-57.0%
5Y
-90.8%
Pipeline Summary
12 total trials4
Phase 1
6
Phase 2
2
Phase 3
0
Phase 4
Terminated: 5Completed: 6Recruiting: 1
Active Trials (1)
Open-label Extension Study in Participants With Early Alzheimer's Disease
NCT07105709Alzheimer's Disease
Phase 2Recruiting
Enrollment: 220 participants
Key Facts
Market Cap$339.5M
Employees103 (-57% YoY)
CEOArnon Rosenthal
IPO DateFeb 7, 2019
Beta0.61
52-Week Range$1.09 – $2.76
Avg Volume2,555,349
ExchangeNASDAQ
Websitealector.com
Ownership
Float68.6%
Shares Outstanding148.3M
Recent Insider Trades
Rosenthal ArnonAWARD
Oct 14, 2026217,500 shares
Rosenthal ArnonAWARD
Oct 14, 2026978,750 shares @ $1.88
Rosenthal ArnonAWARD
Oct 13, 2026520,000 shares @ $1.87
Rosenthal ArnonAWARD
Oct 13, 2026500,000 shares @ $1.87
Rosenthal ArnonAWARD
Oct 13, 2026457,038 shares @ $1.87
Peers
Recent News
Alector Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 5, 2026 · globenewswire.com
Will Alector (ALEC) Report Negative Q3 Earnings? What You Should Know
Oct 29, 2026 · zacks.com
Alector Announces Pricing of Underwritten Offering
Oct 16, 2026 · globenewswire.com
Alector, Inc. (ALEC) Discusses Strategic Advances in Next Generation Neurodegeneration Therapies and Pipeline Developments Transcript
Oct 13, 2026 · seekingalpha.com
Alector Maps Brain-Delivery Pipeline for Alzheimer's, Parkinson's Therapies
Oct 13, 2026 · marketbeat.com
Data last updated: Nov 9, 2026, 03:53 AM